Overview

Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
0
Participant gender:
Male
Summary
This study evaluates the intervention of the 1) sodium-restricted diet, or 2) diuretic, or 3) placebo pill in the treatment of obstructive sleep apnea in adults.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Treatments:
Diuretics
Furosemide
Spironolactone
Criteria
Inclusion Criteria:

- Men in the age range from 18 to 60 years

- Full-night in-laboratory polysomnography with apnea-hypopnea index > 30/h in the last
three months

- Body mass index < 35 kg/m2

- Informed consent

Exclusion Criteria:

- Already having started any treatment for sleep apnea, including use of continuous
positive airway pressure

- NYHA heart failure, any class

- Predominantly central apnea

- Peripheral venous or lymphatic insufficiency

- Any chronic renal disease

- Use of diuretics and substances with action in the central or peripheral nervous
system such as benzodiazepines, hypnotics, anticonvulsants, antidepressants, appetite
suppressants, amphetamines, antiparkinson agents, muscle relaxants, bronchodilators

- Stroke within 6 months or with incapacitating sequelae

- Any physical, mental or social condition impairing the ability to participate in the
trial